Compared to Distribution

an indicator guage with the arrow in the green the value is in the best half of communities.

an indicator guage with the arrow in the yellow the value is in the 2nd worst quarter of communities.

an indicator guage with the arrow in the red the value is in the worst quarter of communities.

Compared to Target

green circle with white tick inside it meets target; red circle with white cross inside it does not meet target.

Compared to a Single Value

green diamond with downward arrow inside it lower than the comparison value; red diamond with downward arrow inside it higher than the comparison value; blue diamond with downward arrow inside it not statistically different from comparison value.

Trend

green square outline with upward trending arrow inside it green square outline with downward trending arrow inside it non-significant change over time; green square with upward trending arrow inside it green square with downward trending arrow inside it significant change over time; blue square with equals sign no change over time.

Compared to Prior Value

green triangle with upward trending arrow inside it higher than the previous measurement period; green triangle with downward trending arrow inside it lower than the previous measurement period; blue equals sign no statistically different change from previous measurement period.

green chart bars Significantly better than the overall value

red chart bars Significantly worse than the overall value

light blue chart bars No significant difference with the overall value

gray chart bars No data on significance available

Diabetes Management: Medicare Population

State: Michigan

Measurement Period: 2012

This indicator shows the percentage of diabetic medicare beneficiaries aged 65 to 75 receiving the three recommended tests. These tests are the hemoglobin A1c test, the retinal or dilated eye exam, and the blood lipids test.

Medicare is the federal health insurance program for persons aged 65 years or older, persons under age 65 years with certain disabilities, and persons of any age with end-stage renal disease (ESRD).

Why is this important?

Diabetes is a leading cause of death in the United States. According to the Centers for Disease Prevention and Control and Prevention (CDC), more than 25 million people have diabetes, including both diagnosed and undiagnosed cases. This disease can have a harmful effect on most of the organ systems in the human body; it is a frequent cause of end-stage renal disease, non-traumatic lower-extremity amputation, and a leading cause of blindness among working age adults. Persons with diabetes are also at increased risk for ischemic heart disease, neuropathy, and stroke. In economic terms, the direct medical expenditures attributable to diabetes is over $116 billion (CDC). Diabetes disproportionately affects minority populations and the elderly, and its incidence is likely to increase as minority populations grow and the U.S. population becomes older.

Following a diagnosis of diabetes, a combination of laboratory and clinical tests can be used to monitor blood glucose control, detect onset and progression of diabetic complications, and predict treatment response. The three routine tests are recommended to detect the onset and monitor the progression of the complications and diseases of increased risk due to diabetes.

More...